219 related articles for article (PubMed ID: 33823624)
21. Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn.
Modhave DT; Handa T; Shah RP; Singh S
J Pharm Biomed Anal; 2011 Nov; 56(3):538-45. PubMed ID: 21757313
[TBL] [Abstract][Full Text] [Related]
22. Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC-MS/MS.
Kushwah BS; Thummar MM; Yadav AS; Dhiman V; Samanthula G
Biomed Chromatogr; 2023 Jan; 37(1):e5517. PubMed ID: 36200917
[TBL] [Abstract][Full Text] [Related]
23. Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS.
Yuan Y; Li YB; Tai ZF; Xie YP; Pu XF; Gao J
J Food Drug Anal; 2018 Jan; 26(1):409-415. PubMed ID: 29389581
[TBL] [Abstract][Full Text] [Related]
24. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products.
Jain M; Khan S
J Pharm Biomed Anal; 2022 Sep; 219():114955. PubMed ID: 35917732
[TBL] [Abstract][Full Text] [Related]
26. LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride.
Grover P; Maheshwari S; Nagarajan K; Mehta L; Kumar S; Rastogi C
J Pharm Biomed Anal; 2023 Jan; 223():115119. PubMed ID: 36343537
[TBL] [Abstract][Full Text] [Related]
27. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of major degradation products of Eprinomectin drug substance including degradation pathways using LC-HRMS and NMR.
Adhikari S; Rustum AM
J Pharm Biomed Anal; 2022 Jun; 215():114767. PubMed ID: 35447491
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
30. Separation, identification and characterization of stress degradation products of bortezomib using HPLC and LC-MS.
Purushotham Reddy C; Ramakrishna K; Narayana Rao K
Eur J Mass Spectrom (Chichester); 2021 Apr; 27(2-4):115-125. PubMed ID: 33827302
[TBL] [Abstract][Full Text] [Related]
31. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
Kalariya PD; Talluri MV; Patel PN; Srinivas R
J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of degradation products of indacaterol using liquid chromatography/mass spectrometry.
Yerra NV; Dadinaboyina SB; Vigjna Abbaraju L; Kumar Talluri M; Reddy Thota J
Eur J Mass Spectrom (Chichester); 2020 Dec; 26(6):425-431. PubMed ID: 33153322
[TBL] [Abstract][Full Text] [Related]
33. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
34. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
Prajapati KJ; Kothari CS
Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
[TBL] [Abstract][Full Text] [Related]
37. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
Chadha R; Bali A; Bansal G
J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of stress degradation products of febuxostat employing ultra-performance liquid chromatography-ultraviolet/photodiode array and liquid chromatography-mass spectrometry/time-of-flight studies.
Saha M; Bali A; Patra SR; Singh J
Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9423. PubMed ID: 36278931
[TBL] [Abstract][Full Text] [Related]
39. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
Tiwari RN; Bonde CG
J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
[TBL] [Abstract][Full Text] [Related]
40. Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity.
Dhiman V; Balhara A; Singh S; Tiwari S; Gananadhamu S; Talluri MVNK
J Pharm Biomed Anal; 2021 May; 199():114037. PubMed ID: 33836462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]